Athos Therapeutics Announces their Corporate Circle Membership to the Crohn’s & Colitis Foundation and Participation in the "IBD Innovate" Conference

LOS ANGELES: LOS ANGELES, Oct. 13, 2021 /PRNewswire/ -- Athos Therapeutics, Inc., a late preclinical stage biotechnology company pioneering the development of first-in-class precision therapeutics for patients with autoimmune diseases and cancer, today announced their Corporate Circle Membership to the Crohn's & Colitis Foundation and participation in the IBD Innovate...

Click to view original post